Philip J. Breen
Researcher
Also affiliated: Massachusetts College of Pharmacy and Health Sciences (1981–1988); Mexfam (2006); Altria (United States) (1989); Colorado State University (1987–1989)
Faculty Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Philip J. Breen's research focuses on the intersection of chemistry, pharmacology, and biology, with a particular emphasis on understanding molecular mechanisms and developing potential therapeutic agents. His work has explored the radioprotective effects of tocotrienols, investigating their dual roles as antioxidants and signaling molecules across multiple organ systems. Breen has also investigated compounds with antileukemic properties derived from plant-plant interactions.
His laboratory has conducted pharmacokinetic studies, including an analysis of morphine-6-O-sulfate in rat plasma and brain. Furthermore, Breen's research group has been involved in the development of novel tocotrienol analogues, such as tocoflexol, for potential use as radiomitigators. His scholarship is evidenced by a high-impact designation, with 49 publications and 1,880 citations, and an h-index of 20. He leads a research group and collaborates with several faculty members at the University of Arkansas for Medical Sciences, including Darin E. Jones, David E. Mery, Edward J. Selvik, and Nükhet Aykin‐Burns.
Metrics
- h-index: 20
- Publications: 49
- Citations: 1,918
Selected Publications
-
Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects (2023)
-
466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator (2023)
-
Analysis of Plant–Plant Interactions Reveals the Presence of Potent Antileukemic Compounds (2022)
-
A pharmacokinetic study of <scp>morphine‐6‐<i>O</i></scp>‐sulfate in rat plasma and brain (2021)
-
Antioxidant Tocols as Radiation Countermeasures (Challenges to be Addressed to Use Tocols as Radiation Countermeasures in Humans) (2018)
-
Identification of a melampomagnolide B analog as a potential lead molecule for treatment of acute myelogenous leukemia (2016)
-
Corrigendum to “Sesquiterpene lactones from Gynoxys verrucosa and their anti-MRSA activity” [J. Ethnopharmacol. 137 (2011) 1055–1059] (2016)
-
Novel Bone-Targeting Agent for Enhanced Delivery of Vancomycin to Bone (2015)
-
Cyclodextrins in pharmaceutical formulations I: structure and physicochemical properties, formation of complexes, and types of complex (2015)
-
Cyclodextrins in pharmaceutical formulations II: solubilization, binding constant, and complexation efficiency (2015)
-
Tocotrienol-Rich Fraction from Rice Bran Demonstrates Potent Radiation Protection Activity (2015)
-
The smoking habits of the family influence the uptake of e-cigarettes in US children (2014)
-
Drug dissolution: significance of physicochemical properties and physiological conditions (2013)
-
Molecular Dynamics Guided Design of Tocoflexol: A New Radioprotectant Tocotrienol with Enhanced Bioavailability (2013)
-
Sesquiterpene lactones from Gynoxys verrucosa and their anti-MRSA activity (2011)
Grants & Funding
As listed on this researcher's institutional profile.
- Developing Countermeasures for Acute Respiratory Distress Produced by Lunar Dust National Aeronautics & Space Administration via Arkansas Space Grant Consortium
Collaboration Network
Top Collaborators
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- Analysis of Plant–Plant Interactions Reveals the Presence of Potent Antileukemic Compounds
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- Analysis of Plant–Plant Interactions Reveals the Presence of Potent Antileukemic Compounds
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
- A pharmacokinetic study of <scp>morphine‐6‐<i>O</i></scp>‐sulfate in rat plasma and brain
- A pharmacokinetic study of <scp>morphine‐6‐<i>O</i></scp>‐sulfate in rat plasma and brain
- A pharmacokinetic study of <scp>morphine‐6‐<i>O</i></scp>‐sulfate in rat plasma and brain
- A pharmacokinetic study of <scp>morphine‐6‐<i>O</i></scp>‐sulfate in rat plasma and brain
- A pharmacokinetic study of <scp>morphine‐6‐<i>O</i></scp>‐sulfate in rat plasma and brain
- A pharmacokinetic study of <scp>morphine‐6‐<i>O</i></scp>‐sulfate in rat plasma and brain
- Analysis of Plant–Plant Interactions Reveals the Presence of Potent Antileukemic Compounds
- Analysis of Plant–Plant Interactions Reveals the Presence of Potent Antileukemic Compounds
- Analysis of Plant–Plant Interactions Reveals the Presence of Potent Antileukemic Compounds
- Analysis of Plant–Plant Interactions Reveals the Presence of Potent Antileukemic Compounds
Similar Researchers
Based on overlapping research topics